CD4- CD8- 'double-negative' cutaneous T-cell lymphomas share common histologic features and an aggressive clinical course

Dan Jones, Francisco Vega, Andreas H. Sarris, L. Jeffrey Medeiros

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

We report 15 patients with CD4-CD8- "double-negative" T-cell lymphoma arising in skin. There were seven women and eight men with a mean age at diagnosis of 53 years (range 19-77 years). All but two patients presented with solitary or multiple cutaneous nodule(s). Initial and recurrent biopsy specimens showed a dense infiltrate centered in the mid-dermis (extending into subcutis when sampled) of small to intermediate-sized lymphocytes with indistinct nucleoli and frequently irregular nuclear contours. Periadnexal infiltration and epidermal ulceration were present in five cases with the intraepidermal cells being primarily reactive CD4+ T cells. All cases were negative for CD30 and terminal deoxynucleotidyl-transferase; one showed expression of CD56, and six of eight tested cases were positive for T-cell receptor-8 expression. Despite systemic chemotherapy, all 12 patients with clinical follow-up showed recurrent or progressive disease with wide-spread cutaneous dissemination in 10 of 12. Eventual dissemination to lymph nodes or bone marrow occurred in two patients each, with at least nine patients dead of disease or treatment complications. Only two patients achieved lasting clinical remission (with 2′-deoxycoformycin/pentostatin and nelarabine, respectively). CD4-CD8- "double-negative" CTCL has distinctive histologic features and cytomorphology with a marked propensity for rapid multifocal cutaneous dissemination.

Original languageEnglish
Pages (from-to)225-231
Number of pages7
JournalAmerican Journal of Surgical Pathology
Volume26
Issue number2
DOIs
StatePublished - Feb 16 2002
Externally publishedYes

Fingerprint

Cutaneous T-Cell Lymphoma
Pentostatin
Skin
DNA Nucleotidylexotransferase
T-Cell Lymphoma
Dermis
T-Cell Antigen Receptor
Lymph Nodes
Bone Marrow
Lymphocytes
T-Lymphocytes
Biopsy
Drug Therapy

Keywords

  • Gamma-delta T cells
  • Skin disease
  • T-cell lymphoma
  • Tumor markers

ASJC Scopus subject areas

  • Anatomy
  • Pathology and Forensic Medicine

Cite this

CD4- CD8- 'double-negative' cutaneous T-cell lymphomas share common histologic features and an aggressive clinical course. / Jones, Dan; Vega, Francisco; Sarris, Andreas H.; Medeiros, L. Jeffrey.

In: American Journal of Surgical Pathology, Vol. 26, No. 2, 16.02.2002, p. 225-231.

Research output: Contribution to journalArticle

@article{d49bfbbae73349fe83fcbb3bd3b1c2da,
title = "CD4- CD8- 'double-negative' cutaneous T-cell lymphomas share common histologic features and an aggressive clinical course",
abstract = "We report 15 patients with CD4-CD8- {"}double-negative{"} T-cell lymphoma arising in skin. There were seven women and eight men with a mean age at diagnosis of 53 years (range 19-77 years). All but two patients presented with solitary or multiple cutaneous nodule(s). Initial and recurrent biopsy specimens showed a dense infiltrate centered in the mid-dermis (extending into subcutis when sampled) of small to intermediate-sized lymphocytes with indistinct nucleoli and frequently irregular nuclear contours. Periadnexal infiltration and epidermal ulceration were present in five cases with the intraepidermal cells being primarily reactive CD4+ T cells. All cases were negative for CD30 and terminal deoxynucleotidyl-transferase; one showed expression of CD56, and six of eight tested cases were positive for T-cell receptor-8 expression. Despite systemic chemotherapy, all 12 patients with clinical follow-up showed recurrent or progressive disease with wide-spread cutaneous dissemination in 10 of 12. Eventual dissemination to lymph nodes or bone marrow occurred in two patients each, with at least nine patients dead of disease or treatment complications. Only two patients achieved lasting clinical remission (with 2′-deoxycoformycin/pentostatin and nelarabine, respectively). CD4-CD8- {"}double-negative{"} CTCL has distinctive histologic features and cytomorphology with a marked propensity for rapid multifocal cutaneous dissemination.",
keywords = "Gamma-delta T cells, Skin disease, T-cell lymphoma, Tumor markers",
author = "Dan Jones and Francisco Vega and Sarris, {Andreas H.} and Medeiros, {L. Jeffrey}",
year = "2002",
month = "2",
day = "16",
doi = "10.1097/00000478-200202000-00009",
language = "English",
volume = "26",
pages = "225--231",
journal = "American Journal of Surgical Pathology",
issn = "0147-5185",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - CD4- CD8- 'double-negative' cutaneous T-cell lymphomas share common histologic features and an aggressive clinical course

AU - Jones, Dan

AU - Vega, Francisco

AU - Sarris, Andreas H.

AU - Medeiros, L. Jeffrey

PY - 2002/2/16

Y1 - 2002/2/16

N2 - We report 15 patients with CD4-CD8- "double-negative" T-cell lymphoma arising in skin. There were seven women and eight men with a mean age at diagnosis of 53 years (range 19-77 years). All but two patients presented with solitary or multiple cutaneous nodule(s). Initial and recurrent biopsy specimens showed a dense infiltrate centered in the mid-dermis (extending into subcutis when sampled) of small to intermediate-sized lymphocytes with indistinct nucleoli and frequently irregular nuclear contours. Periadnexal infiltration and epidermal ulceration were present in five cases with the intraepidermal cells being primarily reactive CD4+ T cells. All cases were negative for CD30 and terminal deoxynucleotidyl-transferase; one showed expression of CD56, and six of eight tested cases were positive for T-cell receptor-8 expression. Despite systemic chemotherapy, all 12 patients with clinical follow-up showed recurrent or progressive disease with wide-spread cutaneous dissemination in 10 of 12. Eventual dissemination to lymph nodes or bone marrow occurred in two patients each, with at least nine patients dead of disease or treatment complications. Only two patients achieved lasting clinical remission (with 2′-deoxycoformycin/pentostatin and nelarabine, respectively). CD4-CD8- "double-negative" CTCL has distinctive histologic features and cytomorphology with a marked propensity for rapid multifocal cutaneous dissemination.

AB - We report 15 patients with CD4-CD8- "double-negative" T-cell lymphoma arising in skin. There were seven women and eight men with a mean age at diagnosis of 53 years (range 19-77 years). All but two patients presented with solitary or multiple cutaneous nodule(s). Initial and recurrent biopsy specimens showed a dense infiltrate centered in the mid-dermis (extending into subcutis when sampled) of small to intermediate-sized lymphocytes with indistinct nucleoli and frequently irregular nuclear contours. Periadnexal infiltration and epidermal ulceration were present in five cases with the intraepidermal cells being primarily reactive CD4+ T cells. All cases were negative for CD30 and terminal deoxynucleotidyl-transferase; one showed expression of CD56, and six of eight tested cases were positive for T-cell receptor-8 expression. Despite systemic chemotherapy, all 12 patients with clinical follow-up showed recurrent or progressive disease with wide-spread cutaneous dissemination in 10 of 12. Eventual dissemination to lymph nodes or bone marrow occurred in two patients each, with at least nine patients dead of disease or treatment complications. Only two patients achieved lasting clinical remission (with 2′-deoxycoformycin/pentostatin and nelarabine, respectively). CD4-CD8- "double-negative" CTCL has distinctive histologic features and cytomorphology with a marked propensity for rapid multifocal cutaneous dissemination.

KW - Gamma-delta T cells

KW - Skin disease

KW - T-cell lymphoma

KW - Tumor markers

UR - http://www.scopus.com/inward/record.url?scp=0036158928&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036158928&partnerID=8YFLogxK

U2 - 10.1097/00000478-200202000-00009

DO - 10.1097/00000478-200202000-00009

M3 - Article

VL - 26

SP - 225

EP - 231

JO - American Journal of Surgical Pathology

JF - American Journal of Surgical Pathology

SN - 0147-5185

IS - 2

ER -